FREMONT, Calif., Sept. 1 /PRNewswire-FirstCall/ -- Abgenix, Inc.
(Nasdaq: ABGX) today announced that it has been invited to present at three
upcoming investor conferences. Each of the presentations will be accessible
through the Abgenix website. Following is the schedule of presentations:
* Thomas Weisel Partners Healthcare Tailwinds Conference -- September
8, 2005 at 10:30 a.m. Eastern Time
* BioCentury NewsMakers in the Biotech Industry Conference --
September 9, 2005 at 10:00 a.m. Eastern Time
* Bear Stearns 18th Annual Healthcare Conference -- September 12, 2005
at 10:30 a.m. Eastern Time
To access the live webcast or the subsequent archived recording, please
visit the Abgenix website at http://www.abgenix.com.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery,
development and manufacturing of human therapeutic antibodies. The company's
antibody development platform includes a leading technology and state-of-the-
art manufacturing capabilities that enable the rapid generation, selection and
production of high affinity, fully human antibody product candidates to a
variety of disease targets. Abgenix leverages its leadership position in human
antibody technology to build a diversified product portfolio through its own
development efforts and the establishment of collaborations with multiple
pharmaceutical and biotechnology companies. For more information on Abgenix,
visit the company's website at http://www.abgenix.com.
SOURCE Abgenix, Inc.
 back to top
Related links:
http://www.abgenix.com
CONTACT:
Greg Mann, Director of Corporate
Communications & Investor Relations of Abgenix, Inc.,
+1-510-284-6566
|
